Cargando…

PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction

Detalles Bibliográficos
Autores principales: Gardner, Eliot L., Bi, Guo-Hua, Thakur, Ganesh, Makriyannis, Alexandros, Seltzman, Herbert H., He, Xiang-Hu, Xi, Zheng-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616224/
http://dx.doi.org/10.1093/ijnp/pyw041.288
_version_ 1783266731028905984
author Gardner, Eliot L.
Bi, Guo-Hua
Thakur, Ganesh
Makriyannis, Alexandros
Seltzman, Herbert H.
He, Xiang-Hu
Xi, Zheng-Xiong
author_facet Gardner, Eliot L.
Bi, Guo-Hua
Thakur, Ganesh
Makriyannis, Alexandros
Seltzman, Herbert H.
He, Xiang-Hu
Xi, Zheng-Xiong
author_sort Gardner, Eliot L.
collection PubMed
description
format Online
Article
Text
id pubmed-5616224
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56162242017-11-27 PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction Gardner, Eliot L. Bi, Guo-Hua Thakur, Ganesh Makriyannis, Alexandros Seltzman, Herbert H. He, Xiang-Hu Xi, Zheng-Xiong Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616224/ http://dx.doi.org/10.1093/ijnp/pyw041.288 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Gardner, Eliot L.
Bi, Guo-Hua
Thakur, Ganesh
Makriyannis, Alexandros
Seltzman, Herbert H.
He, Xiang-Hu
Xi, Zheng-Xiong
PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
title PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
title_full PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
title_fullStr PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
title_full_unstemmed PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
title_short PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
title_sort pm288. preclinical evaluation of neutral cannabinoid cb1 receptor antagonists and cannabinoid cb1 receptor negative allosteric modulators for treating drug addiction
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616224/
http://dx.doi.org/10.1093/ijnp/pyw041.288
work_keys_str_mv AT gardnereliotl pm288preclinicalevaluationofneutralcannabinoidcb1receptorantagonistsandcannabinoidcb1receptornegativeallostericmodulatorsfortreatingdrugaddiction
AT biguohua pm288preclinicalevaluationofneutralcannabinoidcb1receptorantagonistsandcannabinoidcb1receptornegativeallostericmodulatorsfortreatingdrugaddiction
AT thakurganesh pm288preclinicalevaluationofneutralcannabinoidcb1receptorantagonistsandcannabinoidcb1receptornegativeallostericmodulatorsfortreatingdrugaddiction
AT makriyannisalexandros pm288preclinicalevaluationofneutralcannabinoidcb1receptorantagonistsandcannabinoidcb1receptornegativeallostericmodulatorsfortreatingdrugaddiction
AT seltzmanherberth pm288preclinicalevaluationofneutralcannabinoidcb1receptorantagonistsandcannabinoidcb1receptornegativeallostericmodulatorsfortreatingdrugaddiction
AT hexianghu pm288preclinicalevaluationofneutralcannabinoidcb1receptorantagonistsandcannabinoidcb1receptornegativeallostericmodulatorsfortreatingdrugaddiction
AT xizhengxiong pm288preclinicalevaluationofneutralcannabinoidcb1receptorantagonistsandcannabinoidcb1receptornegativeallostericmodulatorsfortreatingdrugaddiction